269 related articles for article (PubMed ID: 8828740)
1. Interleukin-10-induced HIV-1 expression is mediated by induction of both membrane-bound tumour necrosis factor (TNF)-alpha and TNF receptor type 1 in a promonocytic cell line.
Barcellini W; Rizzardi GP; Marriott JB; Fain C; Shattock RJ; Meroni PL; Poli G; Dalgleish AG
AIDS; 1996 Jul; 10(8):835-42. PubMed ID: 8828740
[TBL] [Abstract][Full Text] [Related]
2. Soluble tumor necrosis factor receptors inhibit phorbol myristate acetate and cytokine-induced HIV-1 expression chronically infected U1 cells.
Granowitz EV; Saget BM; Angel JB; Wang MZ; Wang A; Dinarello CA; Skolnik PR
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):430-7. PubMed ID: 8605587
[TBL] [Abstract][Full Text] [Related]
3. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage.
Finnegan A; Roebuck KA; Nakai BE; Gu DS; Rabbi MF; Song S; Landay AL
J Immunol; 1996 Jan; 156(2):841-51. PubMed ID: 8543841
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor receptor p55 mediates induction of HIV type 1 expression in chronically infected U1 cells.
Edfjäll C; Jacobsen H; Lötscher H; Mous J
AIDS Res Hum Retroviruses; 1996 Feb; 12(3):199-204. PubMed ID: 8835197
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-10 enhances human immunodeficiency virus type 1 expression in a chronically infected promonocytic cell line (U1) by a tumor necrosis factor alpha-independent mechanism.
Angel JB; Saget BM; Wang MZ; Wang A; Dinarello CA; Skolnik PR
J Interferon Cytokine Res; 1995 Jun; 15(6):575-84. PubMed ID: 7553227
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-10 enhances tumor necrosis factor-alpha activation of HIV-1 transcription in latently infected T cells.
Rabbi MF; Finnegan A; Al-Harthi L; Song S; Roebuck KA
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):321-31. PubMed ID: 9833740
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.
Granowitz EV; Saget BM; Wang MZ; Dinarello CA; Skolnik PR
Mol Med; 1995 Sep; 1(6):667-77. PubMed ID: 8529133
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma.
Galve-de Rochemonteix B; Nicod LP; Dayer JM
Am J Respir Cell Mol Biol; 1996 Mar; 14(3):279-87. PubMed ID: 8845179
[TBL] [Abstract][Full Text] [Related]
9. Expression of tumor necrosis factor-alpha and its receptors type I and type II in human oocytes.
Naz RK; Zhu X; Menge AC
Mol Reprod Dev; 1997 Jun; 47(2):127-33. PubMed ID: 9136112
[TBL] [Abstract][Full Text] [Related]
10. Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor.
Alsalameh S; Mattka B; Al-Ward R; Lorenz HM; Manger B; Pfizenmaier K; Grell M; Kalden JR
J Rheumatol; 1999 Mar; 26(3):645-53. PubMed ID: 10090177
[TBL] [Abstract][Full Text] [Related]
11. Enhanced murine macrophage TNF receptor shedding by cytosine-guanine sequences in oligodeoxynucleotides.
Jin L; Raymond DP; Crabtree TD; Pelletier SJ; Houlgrave CW; Pruett TL; Sawyer RG
J Immunol; 2000 Nov; 165(9):5153-60. PubMed ID: 11046047
[TBL] [Abstract][Full Text] [Related]
12. IL-2-induced tumor necrosis factor (TNF)-beta expression: further analysis in the IL-2 knockout model, and comparison with TNF-alpha, lymphotoxin-beta, TNFR1 and TNFR2 modulation.
Reddy J; Chastagner P; Fiette L; Liu X; Thèze J
Int Immunol; 2001 Feb; 13(2):135-47. PubMed ID: 11157847
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: low percentage of p75-tumor necrosis factor receptor positive cells in patients with advanced disease and high viral load.
Hestdal K; Aukrust P; Müller F; Lien E; Bjerkeli V; Espevik T; Frøland SS
Blood; 1997 Oct; 90(7):2670-9. PubMed ID: 9326234
[TBL] [Abstract][Full Text] [Related]
14. Toxoplasma gondii infection can regulate the expression of tumour necrosis factor-alpha receptors on human cells in vitro.
Derouich-Guergour D; Aldebert D; Vigan I; Jouvin-Marche E; Marche PN; Aubert D; Ambroise-Thomas P; Pelloux H
Parasite Immunol; 2002 May; 24(5):271-9. PubMed ID: 12060321
[TBL] [Abstract][Full Text] [Related]
15. Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization.
Boldrini L; Calcinai A; Samaritani E; Pistolesi F; Mussi A; Lucchi M; Angeletti CA; Basolo F; Fontanini G
Br J Cancer; 2000 Aug; 83(4):480-6. PubMed ID: 10945495
[TBL] [Abstract][Full Text] [Related]
16. Expression of the 75 kDA TNF receptor and its role in contact-mediated neuronal cell death.
Sipe KJ; Dantzer R; Kelley KW; Weyhenmeyer JA
Brain Res Mol Brain Res; 1998 Nov; 62(2):111-21. PubMed ID: 9813268
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 alpha upregulates tumor necrosis factor receptors expressed by a human bone marrow stromal cell strain: implications for cytokine redundancy and synergy.
Caldwell J; Emerson SG
Blood; 1995 Nov; 86(9):3364-72. PubMed ID: 7579439
[TBL] [Abstract][Full Text] [Related]
18. The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitro.
La Maestra L; Zaninoni A; Marriott JB; Lazzarin A; Dalgleish AG; Barcellini W
Clin Exp Immunol; 2000 Jan; 119(1):123-9. PubMed ID: 10606973
[TBL] [Abstract][Full Text] [Related]
19. Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection.
Kallinowski B; Haseroth K; Marinos G; Hanck C; Stremmel W; Theilmann L; Singer MV; Rossol S
Clin Exp Immunol; 1998 Feb; 111(2):269-77. PubMed ID: 9486392
[TBL] [Abstract][Full Text] [Related]
20. HIV type 1 Tat inhibits tumor necrosis factor alpha-induced repression of tumor necrosis factor receptor p55 and amplifies tumor necrosis factor alpha activity in stably tat-transfected HeLa Cells.
Chiao C; Bader T; Stenger JE; Baldwin W; Brady J; Barrett JC
AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1125-32. PubMed ID: 11522182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
